Laporan Kasus Cutaneus Discoid Lupus Erythematosus
Article Sidebar
-
cutaneus discoid lupus erythematosus, SLE, lupus
Abstract
Cutaneus Discoid Lupus Erythematosus (CDLE) merupakan penyakit autoimun sistemik dengan penyebab multifaktor, yang ditandai keterlibatan beberapa organ dan sistem oleh karena kelainan imunologi. Manifestasi klinis CDLE bervariasi dan melibatkan banyak organ baik beberapa organ berbeda maupun berkaitan selama periode penyakit berlangsung. Tujuan penulisan laporan kasus ini adalah untuk mengetahui gejala, tatalaksana terapi dan prognosa dari penyakit ini. Penatalaksanaan CDLE bertujuan untuk mencegah terbentuknya lesi baru dan progresivitas dari lesi yang sudah ada melalui edukasi terhadap pasien dan terapi lokal serta sistemik. Penderita dengan CDLE umumnya bersifat lebih jinak dibanding subtipe CLE lainnya. Laporan kasus ini membahas seorang pasien laki-laki, 41 tahun, dengan keluhan bercak merah yang awalnya di belakang telinga menjalar ke wajah dan menyebar ke kulit kepala, dada, punggung, dan sebagian lengan, serta perjalanan penyakitnya hingga pasien rawat jalan. (QM 2017;01:48-59)
Full text article
References
Achtman, JC., Werth, VP. (2015) Patophysiology of Cutaneous Lupus Erythemathosus, Arthritis Research and Therapy. 17, pp.182.
Bertsias, G., Cervera, R., Boumpas, DT. (2012) Systemic Lupus Erythemathosus: Pathogenesis and Clinical Features, EULAR Textbook on Rheumatic Diseases, pp.476-505.
Biazar, C., Sigges, J., Nikolaos, P. et al. (2013) ‘Cutaneous lupus erythematosus: First Multicenter Database Analysis of 1002 Patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)’. Autoimmunity Review 12, pp.444–454.
Cervera, R., Espinosa, G., D'Cruz, D. (2009) Systemic Lupus Erythematosus: Pathogenesis, Clinical Manifestations and Diagnosi,. Eular Compendium on Rheumatic Diseases, pp.257-268, Italy: BMJ Publishing Group.
Chang, AY., Werth, VP. (2011) Treatment of Cutaneous Lupus. Current Rheumatol. Report. 13(4), pp.300–7.
Chong, BF., Song, J., Olsen, NJ. (2012) Determining Risk Factors for Developing Systemic Lupus Erythematosus in Patients with DLE, British J Dermatol. 166(1) pp.29–35.
Durosaro, O., Davis MD, Reed, KB., Rohlinger, AL. (2009) Incidence of Cutaneous Lupus Erythematosus, 1965-2005: a population based study. Arch Dermatol. 145(3), pp.249-253.
Erceg, A., Bovenschen, HJ., van de Kerkhof, PC, et al. (2009) Efficacy and Safety of Pulsed Dye Laser Treatment for Cutaneous Discoid Lupus Erythematosus, J American Academy Dermatol. 60(4) pp.626–632.
Frances, C., Cosnes, A., Duhaut, P. et al (2012) Low Blood Concentration of Hydroxychloroquine in Patients with Refractory Cutaneous Lupus Erythematosus: a French Multicenter Prospective Study, J Dermatol. 148(4), pp.479–484.
Hallegua, DS., Wallace, J. (2007) Gastrointestinal and Hepatic Manifestasion,. Dubois’ Lupus Erythematosus, 7th edition. Lippincot Williams&Wilkins, pp. 841-847.
Freire, EAM., Souto, LM., Ciconelli, RM. (2011) Assessment measures in systemic lupus erythematosus, Review Brasilian Rheumatol. 51 pp.75-80.
Jemec, GB., Ullman, S., Goodfield, M et al. (2009) A Randomized Controlled Trial of R- salbutamol for Topical Treatment of Discoid Lupus Erythematosus. British J Dermatol. 161(6), pp.1365–1370.
Jessop, S., Whitelaw, DA., Delamere, FM (2009) ‘Drugs for Discoid Lupus Erythematosus’. Cochrane Database System Review. pp.4-10
Kuhn, A., Sonntag, M., Richter-Hintz, D. et al. (2001) Phototesting in Lupus Erythematosus: a 15-year Experience. J American Academy Dermatol. 45(1), pp.86–95.
Lauren, GO., Victoria, PW. (2013) Cutaneus Lupus Erythematosus : Diagnosis and Treatment. Best Practice Clin. Rheumatol. 27(3), pp.391-404
Lee, LA., Werth, VP., Bolognia, JL. (2012) Lupus Erythematosus. Dermatology. 3rd ed. pp.601, London : Elsevier Ltd.
Machado, APB., Dykyj, MT., Vandresen, N., Skare, TL. (2008) Mucocutaneous involvement in 8.systemic lupus erythematosus and its association with autoantibodies. Brasilian Dermatol. 83, pp.323-328.
McCauliffe, DP. (2001) Cutaneous Lupus Erythematosus. Seminar of Cutaneus Medical Surgery. 20, pp.14–26.
Patel, P., Werth, VP. (2002) ‘Cutaneous Lupus Erythematosus’ : a Review. Dermatol. Clin. J. 20, pp.3–385.
Petri, M., Orbal, AM., Alarcon, GS. et al.
(2012) Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythemathosus. Arthritis Rheumatol J. 64, pp.2677-2686
Sontheimer, RD., McCaulife, DP. (2007), Lupus Specific Skin Disease (Cutanoeus LE). Dubois Lupus Erythematosus 7th edition. Lippincot Williams&Wilkins. pp.576-611
Sticherling, M. (2011) ‘Update on the use of topical calcineurin inhibitors in cutaneous 13’. Lupus Erythematous. Biologics 5, pp.21-31.
Tzung, TY., Liu, YS., Chang, HW. (2007) Tacrolimus vs. Clobetasol Propionate in the Treatment of Facial Cutaneous Lupus Erythematosus: a Randomized, Double-blind, Bilateral Comparison Study. British J Dermatol. 156(1), pp.191–192.
Vera-Recabarren, MA., Garcia-Carrasco, M., Ramos-Casals, M., Herrero, C. (2010) Comparative Analysis of Subacute Cutaneous Lupus Erythematosus and Chronic Cutaneous Lupus Erythematosus: Clinical and Immunological Study of 270 Patients. British J Dermatol. 162. pp.91–101.
Walling, HW., Sontheimer, RD. (2009) Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment. American J Clin. Dermatol. 10(6), pp.365–381.
Weber, F., Fritsch, P. (2003) Clinical Differential diagnosis of Cutaneous Lupus Erythemathosus. British J Dermatol. (11), pp.147-16
Authors
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.